Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impax to Sell Authorized Generic Renvela
Yahoo/Zacks.com
Friday, April 18, 2014 - 8:58am
tags:
Impax Labs, generics, Sanofi, Renvela, chronic kidney disease
The Law of Gravity Isn't Working for This Off-Patent Drug
Bloomberg Businessweek
Friday, April 18, 2014 - 8:52am
tags:
patents, Diovan, Novartis, generics, Ranbaxy
FDA Grants Fast Track Status To Amgen Heart Failure Drug
Forbes
Friday, April 18, 2014 - 8:51am
tags:
FDA, Amgen, fast track, ivabradine, heart failure
Johnson & Johnson's 3 Major Strengths
Motley Fool
Thursday, April 17, 2014 - 4:08pm
tags:
JNJ
FDA approves Ragwitek for short ragweed pollen allergies
FDA
Thursday, April 17, 2014 - 4:06pm
tags:
FDA, ragweed pollen allergy, Ragwitek, Merck
Zogenix Shares Soar on Massachusetts Developments
Yahoo/Zacks.com
Thursday, April 17, 2014 - 3:51pm
tags:
Zogenix, Zohydro ER, Massachusetts
2 Reasons Why Merck & Co. Is Crushing the Dow
Motley Fool
Thursday, April 17, 2014 - 12:21pm
tags:
Merck
Pharma Gets Social: Pinterest for Pharma, revisited
Pharmaforum
Thursday, April 17, 2014 - 12:17pm
tags:
social media, Pinterest
England agrees funding for Gilead hepatitis C drug
Yahoo/Reuters
Thursday, April 17, 2014 - 12:10pm
tags:
England, Gilead, hepatitis C, Sovaldi
FDA warns Endo Health on AMS pelvic mesh plant
Mass Device
Thursday, April 17, 2014 - 12:09pm
tags:
FDA, pelvic mesh, devices, Endo Health Solutions, American Medical Systems
AbbVie Candidate in Pivotal Study
Yahoo/Zacks.com
Thursday, April 17, 2014 - 11:51am
tags:
AbbVie, veliparib, non-small cell lung cancer
Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Motley Fool
Thursday, April 17, 2014 - 11:49am
tags:
Sovaldi, hepatitis C, Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, Express Scripts
StemCells completes enrollment in spinal cord injury trial
Yahoo/Fly on the Wall
Thursday, April 17, 2014 - 11:22am
tags:
StemCells, spinal cord injury, HuCNS-SC
Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Motley Fool
Thursday, April 17, 2014 - 11:19am
tags:
Amgen, Biogen Idec, earnings
Generic Drugmakers Fight Teva’s Bid to Stall Competition
Wall St Cheat Sheet
Thursday, April 17, 2014 - 10:57am
tags:
generics, Teva, Copaxone, MS, multiple sclerosis
Teva, Pfizer settle patent lawsuit over blockbuster painkiller
Yahoo/Reuters
Thursday, April 17, 2014 - 10:56am
tags:
Teva, Pfizer, patents, Celebrex
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thursday, April 17, 2014 - 8:29am
tags:
M&A, Amgen, ONYX Pharmaceuticals, Bausch & Lomb, Valeant Pharmaceuticals, Elan, Perrigo, Actavis, Warner Chilcott, Bristol-Myers Squibb, AstraZeneca, Pearl Therapeutics, Agila, Mylan, Salix, Santarus, Bayer, Algeta, Shire, ViroPharma
Dynavax initiates PhIII study it hopes will quell FDA's safety concerns
Fierce Vaccines
Thursday, April 17, 2014 - 8:26am
tags:
Dynavax, FDA, Heplisav
Industry Sees Much not to ‘Like’ in FDA's First Social Media Guidance Document
Regulatory Focus
Thursday, April 17, 2014 - 8:05am
tags:
FDA, social media
Actelion May Raise Forecast After First-Quarter Earnings
Bloomberg
Thursday, April 17, 2014 - 8:03am
tags:
Actelion, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.